Furthermore, we called single nucleotide variants to confirm that mutations of the IDH1 and IDH2 genes, which are mutated in about 10% of human high-grade gliomas, had not spontaneously occurred during in vivo passaging and tumor development (Figure S2C). Here, IDH1 is linked to central nervous system cancer.